Cargando…

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease

We describe our experience with a juvenile patient who had refractory intestinal Behcet's disease that responded to adalimumab, a fully humanized antibody against soluble TNF-α and its receptor. The patient, a 13-year-old girl, presented with oral aphthous ulcers, vulvar pain, and rashes on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaji, Mariko, Kishi, Takayuki, Miyamae, Takako, Nagata, Satoru, Yamanaka, Hisashi, Fujikawa, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644826/ https://www.ncbi.nlm.nih.gov/pubmed/26609459 http://dx.doi.org/10.1155/2015/716138

Ejemplares similares

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody
por: Miyamae, Takako, et al.
Publicado: (2018)

Characteristics of infants born to mothers with autoimmune disorders
por: Kishi, Takayuki, et al.
Publicado: (2014)

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
por: Tanida, Satoshi, et al.
Publicado: (2016)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
por: Park, Jihye, et al.
Publicado: (2017)

Prevalence of polymorphisms of the genes responsible for auto-inflammatory diseases among 202 patients with recurrent fever in a rheumatology institute in Japan
por: Miyamae, Takako, et al.
Publicado: (2014)

Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
por: Liu, PH, et al.
Publicado: (2023)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
por: Kishi, Takayuki, et al.
Publicado: (2021)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
por: Kimura, Masamichi, et al.
Publicado: (2015)

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2010)

PReS-FINAL-2108: Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan
por: Miyamae, T, et al.
Publicado: (2013)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Pulmonary Sarcoidosis in Behçet’s Disease Treated with Adalimumab
por: Louro, Marlene, et al.
Publicado: (2017)

Joint contractures responsive to immunosuppressive therapy in a girl with childhood‐onset systemic sclerosis double‐seropositive for rare anti‐nucleolar autoantibodies: a case report
por: Tanaka, Riki, et al.
Publicado: (2021)

Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2016)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
por: Zou, Jun, et al.
Publicado: (2022)

Refractory Intestinal Behçet-Like Disease Associated with Trisomy 8 Myelodysplastic Syndrome Resolved by Parenteral Nutrition
por: Takahashi, Ryo, et al.
Publicado: (2023)

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
por: Suzuki, Yasuo, et al.
Publicado: (2021)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
por: Inoue, Nagamu, et al.
Publicado: (2017)

Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
por: Kawaguchi, Takaaki, et al.
Publicado: (2022)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet’s Disease with Crohn’s Disease-Like Anal Fistulas
por: Kobashigawa, Tsuyoshi, et al.
Publicado: (2014)

Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab: A case report
por: Yan, Zhe, et al.
Publicado: (2019)

PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome
por: Kishi, T, et al.
Publicado: (2013)

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
por: Suzuki, Taketo, et al.
Publicado: (2019)

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab
por: Hiyama, Tomona, et al.
Publicado: (2019)

Limited efficacy of adalimumab in the acute phase of serpiginous choroiditis refractory to corticosteroid and cyclosporine, a case report
por: Noda, Kazunori, et al.
Publicado: (2019)

Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report
por: Marsili, Manuela, et al.
Publicado: (2016)

Adalimumab for refractory peripheral ulcerative keratitis
por: Cordero-Coma, Miguel, et al.
Publicado: (2012)

Adalimumab in Treating Refractory Livedoid Vasculopathy
por: Huang, Xiao-Wen, et al.
Publicado: (2022)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Lee, Seung Bum, et al.
Publicado: (2023)

Thalamic stroke in a young adult with severe psoriasis refractory to adalimumab
por: Kadayakkara, Deepak Kana, et al.
Publicado: (2015)

Interferon-α2a treatment for refractory Behçet's disease
por: Lai, Yung Jen, et al.
Publicado: (2018)

Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
por: Furuta, Yoki, et al.
Publicado: (2023)

Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2khv5mec9qfjlcb0889ch6t2up